Integer (NYSE:ITGR) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Integer (NYSE:ITGR) released its quarterly earnings data on Thursday. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03), Zacks reports. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million during the quarter, compared to analysts’ expectations of $446.28 million. Integer updated its FY 2025 guidance to 5.840-6.200 EPS.

Integer Stock Down 3.9 %

Shares of NYSE:ITGR opened at $129.96 on Friday. The stock has a market cap of $4.36 billion, a P/E ratio of 38.68, a P/E/G ratio of 1.72 and a beta of 1.13. The firm has a fifty day moving average price of $137.92 and a 200 day moving average price of $132.31. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer has a 1-year low of $98.63 and a 1-year high of $146.36.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Benchmark lifted their price objective on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Friday. Citigroup boosted their price target on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $147.67.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.